FORA (Forian) EPS without NRI: $-0.12 (TTM As of Mar. 2026)


FORA Forian Inc FORA
46 GF Score
Price $2.17
GF Value $3.25
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Forian EPS without NRI?

Forian FORA 46 EPS without NRI is $-0.12 as of Mar. 2026. GuruFocus rates FORA with a GF Score™ of 46/100 and a GF Value™ of $3.25 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Forian ranks better than 88.48% on this metric.

Forian's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.10. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.12.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 49.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 29.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Forian's EPS without NRI or its related term are showing as below:

FORA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 25.1   Med: 48.4   Max: 49.5
Current: 49.5

During the past 7 years, Forian's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 49.50% per year. The lowest was 25.10% per year. And the median was 48.40% per year.

FORA's 3-Year EPS without NRI Growth Rate is ranked better than
88.48% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11 vs FORA: 49.50

Forian's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.16.

Forian's EPS (Basic) for the three months ended in Mar. 2026 was $-0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.16.


Forian  (NAS:FORA) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Forian EPS without NRI Related Terms


Forian EPS without NRI Historical Data

* Premium members only.

The historical data trend for Forian's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forian EPS without NRI Chart

Forian Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -0.91 -0.44 -0.06 -0.12 -0.06

Forian Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.01 0.01 -0.03 -0.10

FORA vs DRIO, ONMD, BEAT: EPS without NRI Comparison

For the Health Information Services subindustry, Forian's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forian PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Forian's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Forian's PE Ratio without NRI falls into.


FORA
46GF Score
Forian Inc FORA
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forian EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.12 mean?
Forian (FORA) has a EPS without NRI of $-0.12 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Forian and its competitors. According to the industry distribution chart, Forian ranks #59 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 11.5%.
Is Forian's EPS without NRI too high?
Forian's current EPS without NRI is $-0.12. Based on the distribution chart, Forian ranks #59 out of 512 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Forian has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Forian's EPS without NRI compare to DRIO and ONMD?
According to the Healthcare Providers & Services industry distribution chart, Forian ranks #59 out of 512 companies for EPS without NRI. This places Forian in the top 12% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Forian and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forian's current EPS without NRI is $-0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forian stock overvalued right now?
Based on GuruFocus' analysis, Forian (FORA) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.25, compared to a current price of $2.17 — trading 33.2% below its estimated fair value. The current EPS without NRI is $-0.12. Forian's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Forian (FORA), the current EPS without NRI is $-0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Forian (FORA) Overvalued in 2026?

Based on GuruFocus' analysis, Forian stock appears to be undervalued. The current stock price of $2.17 is trading 33.2% below its estimated GF Value™ of $3.25. GuruFocus considers Forian to be Significantly Undervalued.

Key valuation signals for FORA:

  • EPS without NRI: $-0.12
  • GF Value™: $3.25 vs. price of $2.17 (33.2% below fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the FORA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Forian Business Description

Address 41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
46GF Score

Get the complete analysis for FORA

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.17
Price
$3.25
GF Value